The potential role of lycopene for the prevention and therapy of prostate cancer: From molecular mechanisms to clinical evidence

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14620-14646

  Holzapfel, Nina Pauline ^a   Holzapfel, Boris Michael ^a   Champ, Simon ^b   Feldthusen, Jesper ^b   Clements, Judith ^c   Hutmacher, Dietmar Werner ^a,d,e  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b BASF SE   (Germany)

^c TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Animal models; Disease prevention; Lycopene; Molecular mechanisms; Prostate cancer; Treatment

Indexed keywords

CAROTENOID; LYCOPENE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOAVAILABILITY; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CELL CYCLE ARREST; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; EVIDENCE BASED MEDICINE; HUMAN; NONHUMAN; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT; VITAMIN METABOLISM;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CAROTENOIDS; CELL CYCLE CHECKPOINTS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DNA DAMAGE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84880120838     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714620     Document Type: Review

References (108)

1. Bray, F.; Lortet-Tieulent, J.; Ferlay, J.; Forman, D.; Auvinen, A. Prostate cancer incidence and mortality trends in 37 European countries: An overview. Eur. J. Cancer 2010, 46, 3040-3052.
2. Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base; International Agency for Research on Cancer: Lyon, France, 2010.
3. Klotz, L. Active surveillance for prostate cancer: Overview and update. Curr. Treat. Options Oncol. 2013, 14, 97-108.
4. Wilt, T.J.; MacDonald, R.; Hagerty, K.; Schellhammer, P.; Kramer, B.S. 5-alpha-reductase inhibitors for prostate cancer prevention. Cochrane Database Syst. Rev. 2008, doi:10.1002/14651858.CD007091.
5. Schmidt, K.; Pittler, M.H.; Ernst, E. A profile of journals of complementary and alternative medicine. Swiss Med. Wkly 2001, 131, 588-591.
6. Foote, J.A.; Murphy, S.P.; Wilkens, L.R.; Hankin, J.H.; Henderson, B.E.; Kolonel, L.N. Factors associated with dietary supplement use among healthy adults of five ethnicities: The multiethnic cohort study. Am. J. Epidemiol. 2003, 157, 888-897.
7. Bishop, F.L.; Rea, A.; Lewith, H.; Chan, Y.K.; Saville, J.; Prescott, P.; von Elm, E.; Lewith, G.T. Complementary medicine use by men with prostate cancer: A systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2011, 14, 1-13.
8. Ponholzer, A.; Struhal, G.; Madersbacher, S. Frequent use of complementary medicine by prostate cancer patients. Eur. Urol. 2003, 43, 604-608.
9. Singh, H.; Maskarinec, G.; Shumay, D.M. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr. Cancer Ther. 2005, 4, 187-194.
10. Chan, J.M.; Elkin, E.P.; Silva, S.J.; Broering, J.M.; Latini, D.M.; Carroll, P.R. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology 2005, 66, 1223-1228.
11. Engelmann, N.J.; Clinton, S.K.; Erdman, J.W., Jr. Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene. Adv. Nutr. 2011, 2, 51-61.
12. Shi, J.; Le Maguer, M. Lycopene in tomatoes: Chemical and physical properties affected by food processing. Crit. Rev. Biotechnol. 2000, 20, 293-334.
13. Agarwal, S.; Rao, A.V. Carotenoids and chronic diseases. Drug Metab. Drug Interact. 2000, 17, 189-210.
14. Britton, G. Structure and properties of carotenoids in relation to function. FASEB J. 1995, 9, 1551-1558.
15. Van Breemen, R.B.; Pajkovic, N. Multitargeted therapy of cancer by lycopene. Cancer Lett. 2008, 269, 339-351.
16. Clinton, S.K. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr. Rev. 1998, 56, 35-51.
17. Clinton, S.K.; Emenhiser, C.; Schwartz, S.J.; Bostwick, D.G.; Williams, A.W.; Moore, B.J.; Erdman, J.W., Jr. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biomarkers Prev. 1996, 5, 823-833.
18. Krinsky, N.I. The antioxidant and biological properties of the carotenoids. Ann. N.Y. Acad. Sci. 1998, 854, 443-447.
19. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 1989, 274, 532-538.
20. Chasse, G.A.; Mak, M.L.; Deretey, E.; Farkas, I.; Torday, L.L.; Papp, J.G.; Sarma, D.S.R.; Agarwal, A.; Chakravarthi, S.; Agarwal, S.; et al. An ab initio computational study on selected lycopene isomers. J. Mol. Struct. Theochem 2001, 571, 27-37.
21. Sies, H.; Stahl, W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 1995, 62, 1315S-1321S.
22. Stahl, W.; Sies, H. Antioxidant activity of carotenoids. Mol. Asp. Med. 2003, 24, 345-351.
23. Bast, A.; Haenen, G.R.; van den Berg, R.; van den Berg, H. Antioxidant effects of carotenoids. Int. J. Vitam. Nutr. Res. 1998, 68, 399-403.
24. Linnewiel, K.; Ernst, H.; Caris-Veyrat, C.; Ben-Dor, A.; Kampf, A.; Salman, H.; Danilenko, M.; Levy, J.; Sharoni, Y. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic. Biol. Med. 2009, 47, 659-667.
25. Khachik, F.; Carvalho, L.; Bernstein, P.S.; Muir, G.J.; Zhao, D.Y.; Katz, N.B. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med. 2002, 227, 845-851.
26. Mangels, A.R.; Holden, J.M.; Beecher, G.R.; Forman, M.R.; Lanza, E. Carotenoid content of fruits and vegetables: An evaluation of analytic data. J. Am. Diet. Assoc. 1993, 93, 284-296.
27. Rao, A.V.; Ali, A. Biologically active phytochemicals in human health: Lycopene. Int. J. Food Prop. 2007, 10, 279-288.
28. Hart, D.J.; Scott, K.J. Development and evaluation of an HPLC method for the analysis of carotenoids in foods, and the measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK. Food Chem. 1995, 54, 101-111.
29. Hallmann, E. The influence of organic and conventional cultivation systems on the nutritional value and content of bioactive compounds in selected tomato types. J. Sci. Food Agric. 2012, 92, 2840-2848.
30. Rossi, F.; Godani, F.; Bertuzzi, T.; Trevisan, M.; Ferrari, F.; Gatti, S. Health-promoting substances and heavy metal content in tomatoes grown with different farming techniques. Eur. J. Nutr. 2008, 47, 266-272.
31. Caris-Veyrat, C.; Amiot, M.J.; Tyssandier, V.; Grasselly, D.; Buret, M.; Mikolajczak, M.; Guilland, J.C.; Bouteloup-Demange, C.; Borel, P. Influence of organic versus conventional agricultural practice on the antioxidant microconstituent content of tomatoes and derived purees; Consequences on antioxidant plasma status in humans. J. Agric. Food Chem. 2004, 52, 6503-6509.
32. Ordonez-Santos, L.; Vazquez-Oderiz, M.; Romero-Rodriguez, M. Micronutrient contents in organic and conventional tomatoes (Solanum lycopersicum L.). Int. J. Food Sci. Technol. 2011, 46, 1561-1568.
33. Tonucci, L.H.; Holden, J.M.; Beecher, G.R.; Khachik, F.; Davis, C.S.; Mulokozi, G. Carotenoid content of thermally processed tomato-based food-products. J. Agric. Food Chem. 1995, 43, 579-586.
34. Stahl, W.; Sies, H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr. 1992, 122, 2161-2166.
35. Parker, R.S. Absorption, metabolism, and transport of carotenoids. FASEB J. 1996, 10, 542-551.
36. Rao, A.V.; Agarwal, S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr. Res. 1999, 19, 305-323.
37. Gartner, C.; Stahl, W.; Sies, H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr. 1997, 66, 116-122.
38. Agarwal A.; Shen, H.; Agarwal, S.; Rao, A.V. Lycopene content of tomato products: Its stability, bioavailability and in vivo antioxidant porperties. J. Med. Food 2001, 4, 9-15.
39. Hussein L.; E.M. Vitamin-A potency of carrot and spinach carotenes in human metabolic studies. Int. J. Vitam. Nutr. Res. 1990, 60, 229-235.
40. Boileau, A.C.; Merchen, N.R.; Wasson, K.; Atkinson, C.A.; Erdman, J.W., Jr. Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J. Nutr. 1999, 129, 1176-1181.
41. Boileau, T.W.M.; Boileau, A.C.; Erdman, J.W. Bioavailability of all-trans and cis-isomers of lycopene. Exp. Biol. Med. 2002, 227, 914-919.
42. Re, R.; Fraser, P.D.; Long, M.; Bramley, P.M.; Rice-Evans, C. Isomerization of lycopene in the gastric milieu. Biochem. Biophys. Res. Commun. 2001, 281, 576-581.
43. Sicilia, T.; Bub, A.; Rechkemmer, G.; Kraemer, K.; Hoppe, P.P.; Kulling, S.E. Novel lycopene metabolites are detectable in plasma of preruminant calves after lycopene supplementation. J. Nutr. 2005, 135, 2616-2621.
44. Honest, K.N.; Zhang, H.W.; Zhang, L.F. Lycopene: Isomerization effects on bioavailability and bioactivity properties. Food Rev. Int. 2011, 27, 248-258.
45. Hoppe, P.P.; Kramer, K.; van den Berg, H.; Steenge, G.; van Vliet, T. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur. J. Nutr. 2003, 42, 272-278.
46. Cohn, W.; Thurmann, P.; Tenter, U.; Aebischer, C.; Schierle, J.; Schalch, W. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur. J. Nutr. 2004, 43, 304-312.
47. Tang, G.; Ferreira, A.L.; Grusak, M.A.; Qin, J.; Dolnikowski, G.G.; Russell, R.M.; Krinsky, N.I. Bioavailability of synthetic and biosynthetic deuterated lycopene in humans. J. Nutr. Biochem. 2005, 16, 229-235.
48. Wertz, K. Lycopene effects contributing to prostate health. Nutr. Cancer 2009, 61, 775-783.
49. Pathak, S.K.; Sharma, R.A.; Steward, W.P.; Mellon, J.K.; Griffiths, T.R.; Gescher, A.J. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: Targets for chemopreventive strategies. Eur. J. Cancer 2005, 41, 61-70.
50. Goo, Y.A.; Li, Z.; Pajkovic, N.; Shaffer, S.; Taylor, G.; Chen, J.; Campbell, D.; Arnstein, L.; Goodlett, D.R.; van Breemen, R.B. Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteom. Clin. Appl. 2007, 1, 513-523.
51. Qiu, X.; Yuan, Y.; Vaishnav, A.; Tessel, M.A.; Nonn, L.; van Breemen, R.B. Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev. Res. 2013, 6, doi:10.1158/1940-6207.CAPR-12-0364.
52. Matos, H.R.; di Mascio, P.; Medeiros, M.H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch. Biochem. Biophys. 2000, 383, 56-59.
53. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21, 361-370.
54. Poirier, M.C.; Santella, R.M.; Weston, A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 2000, 21, 353-359.
55. Hwang, E.S.; Bowen, P.E. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. BioFactors 2005, 23, 97-105.
56. Lowe, G.M.; Booth, L.A.; Young, A.J.; Bilton, R.F. Lycopene and β-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic. Res. 1999, 30, 141-151.
57. Kotake-Nara, E.; Kushiro, M.; Zhang, H.; Sugawara, T.; Miyashita, K.; Nagao, A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 2001, 131, 3303-3306.
58. Hwang, E.S.; Bowen, P.E. Effects of tomato paste extracts on cell proliferation, cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. BioFactors 2005, 23, 75-84.
59. Ivanov, N.I.; Cowell, S.P.; Brown, P.; Rennie, P.S.; Guns, E.S.; Cox, M.E. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and-independent prostate cancer cell lines. Clin. Nutr. 2007, 26, 252-263.
60. Ford, N.A.; Elsen, A.C.; Zuniga, K.; Lindshield, B.L.; Erdman, J.W., Jr. Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr. Cancer 2011, 63, 256-263.
61. Yang, C.M.; Lu, I.H.; Chen, H.Y.; Hu, M.L. Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway. J. Nutr. Biochem. 2012, 23, 8-17.
62. Mueller, E.; Smith, M.; Sarraf, P.; Kroll, T.; Aiyer, A.; Kaufman, D.S.; Oh, W.; Demetri, G.; Figg, W.D.; Zhou, X.P.; et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. USA 2000, 97, 10990-10995.
63. Olefsky, J.M. Nuclear receptor minireview series. J. Biol. Chem. 2001, 276, 36863-36864.
64. Yang, C.M.; Lu, Y.L.; Chen, H.Y.; Hu, M.L. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway. J. Nutr. Biochem. 2012, 23, 1155-1162.
65. Burgess, L.C.; Rice, E.; Fischer, T.; Seekins, J.R.; Burgess, T.P.; Sticka, S.J.; Klatt, K. Lycopene has limited effect on cell proliferation in only two of seven human cell lines (both cancerous and noncancerous) in an in vitro system with doses across the physiological range. Toxicol. In Vitro 2008, 22, 1297-1300.
66. Liu, A.G.; Erdman, J.W., Jr. Lycopene and apo-10'-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells. Biochem. Biophys. Res. Commun. 2011, 412, 479-482.
67. Diehl, J.A. Cycling to cancer with cyclin d1. Cancer Biol. Ther. 2002, 1, 226-231.
68. Palozza, P.; Colangelo, M.; Simone, R.; Catalano, A.; Boninsegna, A.; Lanza, P.; Monego, G.; Ranelletti, F.O. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 2010, 31, 1813-1821.
69. Hantz, H.L.; Young, L.F.; Martin, K.R. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp. Biol. Med. 2005, 230, 171-179.
70. Lim, M.L.; Lum, M.G.; Hansen, T.M.; Roucou, X.; Nagley, P. On the release of cytochrome c from mitochondria during cell death signaling. J. Biomed. Sci. 2002, 9, 488-506.
71. Kanagaraj, P.; Vijayababu, M.R.; Ravisankar, B.; Anbalagan, J.; Aruldhas, M.M.; Arunakaran, J. Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells. J. Cancer Res. Clin. Oncol. 2007, 133, 351-359.
72. Teodoro, A.J.; Oliveira, F.L.; Martins, N.B.; Maia Gde, A.; Martucci, R.B.; Borojevic, R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 2012, 12, doi:10.1186/1475-2867-12-36.
73. Zhang, X.; Wang, Q.; Neil, B.; Chen, X. Effect of lycopene on androgen receptor and prostate-specific antigen velocity. Chin. Med. J. 2010, 123, 2231-2236.
74. Bureyko, T.; Hurdle, H.; Metcalfe, J.B.; Clandinin, M.T.; Mazurak, V.C. Reduced growth and integrin expression of prostate cells cultured with lycopene, Vitamin E and fish oil in vitro. Br. J. Nutr. 2009, 101, 990-997.
75. Tang, Y.; Parmakhtiar, B.; Simoneau, A.R.; Xie, J.; Fruehauf, J.; Lilly, M.; Zi, X. Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor i receptor levels. Neoplasia 2011, 13, 108-119.
76. Lin, C.Y.; Huang, C.S.; Hu, M.L. The use of fetal bovine serum as delivery vehicle to improve the uptake and stability of lycopene in cell culture studies. Br. J. Nutr. 2007, 98, 226-232.
77. Liu, A.; Pajkovic, N.; Pang, Y.; Zhu, D.W.; Calamini, B.; Mesecar, A.L.; van Breemen, R.B. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol. Cancer Ther. 2006, 5, 2879-2885.
78. O'Sullivan, S.M.; Woods, J.A.; O'Brien, N.M. Use of tween 40 and tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br. J. Nutr. 2004, 91, 757-764.
79. Forssberg, A.; Lingen, C.; Ernster, L.; Lindberg, O. Modification of the X-irradiation syndrome by lycopene. Exp. Cell Res. 1959, 16, 7-14.
80. Lingen, C.; Ernster, L.; Lindberg, O. The promoting effect of lycopene on the non-specific resistance of animals. Exp. Cell Res. 1959, 16, 384-393.
81. Ilic, D.; Forbes, K.M.; Hassed, C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst. Rev. 2011, 11, doi:10.1002/14651858.CD008007.pub2.
82. Boileau, T.W.; Liao, Z.; Kim, S.; Lemeshow, S.; Erdman, J.W. Jr.; Clinton, S.K. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J. Natl. Cancer Inst. 2003, 95, 1578-1586.
83. Canene-Adams, K.; Lindshield, B.L.; Wang, S.; Jeffery, E.H.; Clinton, S.K.; Erdman, J.W., Jr. Combinations of tomato and broccoli enhance antitumor activity in dunning R3327-H prostate adenocarcinomas. Cancer Res. 2007, 67, 836-843.
84. Guttenplan, J.B.; Chen, M.; Kosinska, W.; Thompson, S.; Zhao, Z.; Cohen, L.A. Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett. 2001, 164, 1-6.
85. Imaida, K.; Tamano, S.; Kato, K.; Ikeda, Y.; Asamoto, M.; Takahashi, S.; Nir, Z.; Murakoshi, M.; Nishino, H.; Shirai, T. Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. Carcinogenesis 2001, 22, 467-472.
86. Kavanaugh, C.J.; Trumbo, P.R.; Ellwood, K.C. The U.S. Food and drug administration's evidence-based review for qualified health claims: Tomatoes, lycopene, and cancer. J. Natl. Cancer Inst. 2007, 99, 1074-1085.
87. Siler, U.; Barella, L.; Spitzer, V.; Schnorr, J.; Lein, M.; Goralczyk, R.; Wertz, K. Lycopene and vitamin E interfere with autocrine/paracrine loops in the dunning prostate cancer model. FASEB J. 2004, 18, 1019-1021.
88. Siler, U.; Herzog, A.; Spitzer, V.; Seifert, N.; Denelavas, A.; Hunziker, P.B.; Barella, L.; Hunziker, W.; Lein, M.; Goralczyk, R.; et al. Lycopene effects on rat normal prostate and prostate tumor tissue. J. Nutr. 2005, 135, 2050S-2052S.
89. Venkateswaran, V.; Fleshner, N.E.; Sugar, L.M.; Klotz, L.H. Antioxidants block prostate cancer in lady transgenic mice. Cancer Res. 2004, 64, 5891-5896.
90. Yang, C.M.; Yen, Y.T.; Huang, C.S.; Hu, M.L. Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol. Nutr. Food Res. 2011, 55, 606-612.
91. Tang, L.; Jin, T.; Zeng, X.; Wang, J.S. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 2005, 135, 287-290.
92. Konijeti, R.; Henning, S.; Moro, A.; Sheikh, A.; Elashoff, D.; Shapiro, A.; Ku, M.; Said, J.W.; Heber, D.; Cohen, P.; et al. Chemoprevention of prostate cancer with lycopene in the TRAMP model. Prostate 2010, 70, 1547-1554.
93. Canene-Adams, K.; Campbell, J.K.; Zaripheh, S.; Jeffery, E.H.; Erdman, J.W., Jr. The tomato as a functional food. J. Nutr. 2005, 135, 1226-1230.
94. Rackley, J.D.; Clark, P.E.; Hall, M.C. Complementary and alternative medicine for advanced prostate cancer. Urol. Clin. N. Am. 2006, 33, 237-246.
95. Etminan, M.; Takkouche, B.; Caamano-Isorna, F. The role of tomato products and lycopene in the prevention of prostate cancer: A meta-analysis of observational studies. Cancer Epidemiol. Biomark. Prev. 2004, 13, 340-345.
96. Kirsh, V.A.; Mayne, S.T.; Peters, U.; Chatterjee, N.; Leitzmann, M.F.; Dixon, L.B.; Urban, D.A.; Crawford, E.D.; Hayes, R.B. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol. Biomark. Prev. 2006, 15, 92-98.
97. Kristal, A.R.; Till, C.; Platz, E.A.; Song, X.; King, I.B.; Neuhouser, M.L.; Ambrosone, C.B.; Thompson, I.M. Serum lycopene concentration and prostate cancer risk: Results from the prostate cancer prevention trial. Cancer Epidemiol. Biomark. Prev. 2011, 20, 638-646.
98. Peters, U.; Leitzmann, M.F.; Chatterjee, N.; Wang, Y.; Albanes, D.; Gelmann, E.P.; Friesen, M.D.; Riboli, E.; Hayes, R.B. Serum lycopene, other carotenoids, and prostate cancer risk: A nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomark. Prev. 2007, 16, 962-968.
99. Ilic, D.; Misso, M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: A systematic review. Maturitas 2012, 72, 269-276.
100. Bunker, C.H.; McDonald, A.C.; Evans, R.W.; de la Rosa, N.; Boumosleh, J.M.; Patrick, A.L. A randomized trial of lycopene supplementation in tobago men with high prostate cancer risk. Nutr. Cancer 2007, 57, 130-137.
101. Mohanty, N.K.; Saxena, S.; Singh, U.P.; Goyal, N.K.; Arora, R.P. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol. Oncol. 2005, 23, 383-385.
102. Schwarz, S.; Obermuller-Jevic, U.C.; Hellmis, E.; Koch, W.; Jacobi, G.; Biesalski, H.K. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 2008, 138, 49-53.
103. Van Breemen, R.B.; Sharifi, R.; Viana, M.; Pajkovic, N.; Zhu, D.; Yuan, L.; Yang, Y.; Bowen, P.E.; Stacewicz-Sapuntzakis, M. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prev. Res. 2011, 4, 711-718.
104. Ansari, M.S.; Gupta, N.P. A comparison of lycopene and orchidectomy vs. orchidectomy alone in the management of advanced prostate cancer. BJU Int. 2003, 92, 375-378.
105. Grainger, E.M.; Schwartz, S.J.; Wang, S.; Unlu, N.Z.; Boileau, T.W.; Ferketich, A.K.; Monk, J.P.; Gong, M.C.; Bahnson, R.R.; DeGroff, V.L.; et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr. Cancer 2008, 60, 145-154.
106. Kucuk, O.; Sarkar, F.H.; Sakr, W.; Djuric, Z.; Pollak, M.N.; Khachik, F.; Li, Y.W.; Banerjee, M.; Grignon, D.; Bertram, J.S.; et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomark. Prev. 2001, 10, 861-868.
107. Vaishampayan, U.; Hussain, M.; Banerjee, M.; Seren, S.; Sarkar, F.H.; Fontana, J.; Forman, J.D.; Cher, M.L.; Powell, I.; Pontes, J.E.; et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr. Cancer 2007, 59, 1-7.
108. Sporn, M.B.; Liby, K.T. Is lycopene an effective agent for preventing prostate cancer? Cancer Prev. Res. 2013, 6, 384-386.